QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
OTCMKTS:IVOB

Invo Bioscience (IVOB) Stock Forecast, Price & News

$1.06
-0.03 (-2.75%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.06
$1.18
50-Day Range
$1.37
$2.75
52-Week Range
$0.11
$0.46
Volume
81,815 shs
Average Volume
43,036 shs
Market Capitalization
$167.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.81
30 days | 90 days | 365 days | Advanced Chart
Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for Invo Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Invo Bioscience logo

About Invo Bioscience

INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.

Headlines

Invo Bioscience Inc
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IVOB
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
$490 thousand
Book Value
($0.02) per share

Profitability

Net Income
$-3.08 million
Net Margins
-166.95%
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$167.13 million
Optionable
Not Optionable

Company Calendar

Last Earnings
8/14/2018
Today
5/19/2022

MarketRank

Overall MarketRank

1.24 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -













Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

How were Invo Bioscience's earnings last quarter?

Invo Bioscience Inc (OTCMKTS:IVOB) announced its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.11 million for the quarter.
View Invo Bioscience's earnings history
.

Who are Invo Bioscience's key executives?
Invo Bioscience's management team includes the following people:
  • Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 64)
  • Mr. Robert Joseph Bowdring Jr., Acting CFO, Acting Principal Accounting Officer, Treasurer, Sec., Consultant & Director (Age 61)
  • Mr. Michael Jos. Campbell, COO, VP of Bus. Devel. & Director (Age 61)
  • Dr. Kevin Doody, Medical Director & Director (Age 58)
What other stocks do shareholders of Invo Bioscience own?
What is Invo Bioscience's stock symbol?

Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How do I buy shares of Invo Bioscience?

Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invo Bioscience's stock price today?

One share of IVOB stock can currently be purchased for approximately $1.06.

How much money does Invo Bioscience make?

Invo Bioscience has a market capitalization of $167.13 million and generates $490 thousand in revenue each year.

How many employees does Invo Bioscience have?

Invo Bioscience employs 2 workers across the globe.

What is Invo Bioscience's official website?

The official website for Invo Bioscience is www.invobioscience.com.

How can I contact Invo Bioscience?

Invo Bioscience's mailing address is 5582 BROADCAST COURT, SARASOTA FL, 34240. The company can be reached via phone at 978-878-9505 or via email at [email protected].

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.